Patient-specific neural progenitor cells derived from induced pluripotent stem cells offer a promise of good models for mitochondrial disease

被引：0
作者：
Xiao Liang
Cecilie Katrin Kristiansen
Guro Helén Vatne
Yu Hong
Laurence Albert Bindoff
机构：
[1] University of Bergen,The Mitochondrial Medicine and Neurogenetics (MMN) Group, Department of Clinical Medicine
[2] Haukeland University Hospital,Department of Neurology
来源：
Cell and Tissue Research | 2020年 / 380卷
关键词：
Neural progenitor cells; Induced pluripotent stem cells; Mitochondrial disease; mtDNA; Disease modeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Mitochondria are the primary generators of ATP in eukaryotic cells through the process of oxidative phosphorylation. Mitochondria are also involved in several other important cellular functions including regulation of intracellular Ca2+, cell signaling and apoptosis. Mitochondrial dysfunction causes disease and since it is not possible to perform repeated studies in humans, models are essential to enable us to investigate the mechanisms involved. Recently, the discovery of induced pluripotent stem cells (iPSCs), made by reprogramming adult somatic cells (Takahashi and Yamanaka 2006; Yamanaka and Blau 2010), has provided a unique opportunity for studying aspects of disease mechanisms in patient-specific cells and tissues. Reprogramming cells to neuronal lineage such as neural progenitor cells (NPCs) generated from the neural induction of reprogrammed iPSCs can thus provide a useful model for investigating neurological disease mechanisms including those caused by mitochondrial dysfunction. In addition, NPCs display a huge clinical potential in drug screening and therapeutics.
引用
收藏
页码：15 / 30
页数：15
相关论文
共 868 条
[21]  
Ben Jehuda R(1995)MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA (Lys) and premature translation termination Nat Genet 10 47-846
[22]  
Shemer Y(1994)Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome: report of a Chinese family with mitochondrial DNA point mutation in tRNA(Lys) gene Muscle Nerve 17 52-223
[23]  
Binah O(2011)Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming Cell Metab 14 264-925
[24]  
Bhatti JS(2014)Mitochondrial form and function Nature 505 335-1962
[25]  
Bhatti GK(1999)Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease Ann N Y Acad Sci 893 176-E3630
[26]  
Reddy PH(2014)Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations Sci Rep 4 3844-75
[27]  
Blurton-Jones M(2015)Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model Stem Cell Reports 4 835-407
[28]  
Kitazawa M(2013)ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy Am J Hum Genet 93 211-808
[29]  
Martinez-Coria H(2015)Mutations in the two ribosomal RNA genes in mitochondrial DNA among Finnish children with hearing impairment BMC Med Genet 16 3-9339
[30]  
Castello NA(2018)Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes J Cell Mol Med 22 913-524
12345678910